Journal
ULTRASOUND IN MEDICINE AND BIOLOGY
Volume 49, Issue 1, Pages 90-105Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ultrasmedbio.2022.08.005
Keywords
Acoustofluidics; Sonoporation; Drug delivery; fluorescein isothiocyanate; dextran; T lymphocytes
Ask authors/readers for more resources
Continuous-flow acoustofluidic technologies have the potential to enhance T lymphocyte processing for cell therapies. This study compared the intracellular delivery efficiency of acoustofluidic treatment with static ultrasound treatment and found that molecular delivery was similar between the two methods. The acoustofluidic system can significantly improve intracellular molecular delivery and enable acoustofluidic cell transfection in continuous flow processing.
Continuous-flow acoustofluidic technologies can potentially improve processing of T lymphocytes for cell therapies by addressing the limitations with viral and non-viral delivery methods. The objective of this study was to assess the intracellular delivery efficiency with acoustofluidic treatment compared with that of static ultrasound treatment. Optimization of parameters in acoustofluidic and static configurations was performed by assessing intracellular delivery of a fluorescent compound (calcein) in viable human Jurkat T lymphocytes. Ultrasound pressure and the concentration of cationic phospholipid-coated microbubbles influenced calcein delivery in both systems. In the static system, a treatment time of 45 s increased molecular delivery compared with 0-30 s (p < 0.01). Refined parameters were used to assess molecular delivery of small and large compounds (0.6-kDa calcein and 150-kDa fluorescein isothiocyanate- dextran, respectively) after ultrasound treatment with the acoustofluidic or static systems. Molecular delivery was similar with refined parameters for acoustofluidic treatment and static treatment (p > 0.05), even though acoustofluidic treatment had lower microbubble concentration (24 mu g/mL vs. 94 mu g/mL) and shorter treatment time (similar to 2-3 s vs. 45 s). This study indicates that the acoustofluidic system can significantly enhance intracellular molecular delivery, which could potentially enable acoustofluidic cell transfection during continuous flow processing for manufacture of cell therapies or other applications. (c) 2022 World Federation for Ultrasound in Medicine & Biology. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available